A large number of chronic myeloid leukemia (CML) patients are treated with imatinib mesylate outside of clinical trials, which may not be representative of common clinical practice. The age of CML patients enrolled within controlled clinical studies is lower with respect to patients included in population-based registries.

Latagliata, R., Ferrero, D., Iurlo, A., Cavazzini, F., Castagnetti, F., Abruzzese, E., Fava, C., Breccia, M., Annunziata, M., Stagno, F., Tiribelli, M., Binotto, G., Mansueto, G., Gozzini, A., Russo, S., Cavalli, L., Montefusco, E., Gugliotta, G., Cedrone, M., Russo Rossi, A., Avanzini, P., Pregno, P., Mauro, E., Spadea, A., Celesti, F., Giglio, G., Isidori, A., Crugnola, M., Calistri, E., Sora', F., D'Addosio, A., Rege Cambrin, G., Luciano, L., Alimena, G., Storti, S., Imatinib in very elderly patients with chronic myeloid leukemia in chronic phase: a retrospective study, <<DRUGS & AGING>>, 2013; 30 (8): 629-637. [doi:10.1007/s40266-013-0088-6] [http://hdl.handle.net/10807/51127]

Imatinib in very elderly patients with chronic myeloid leukemia in chronic phase: a retrospective study

Sora', Federica;
2013

Abstract

A large number of chronic myeloid leukemia (CML) patients are treated with imatinib mesylate outside of clinical trials, which may not be representative of common clinical practice. The age of CML patients enrolled within controlled clinical studies is lower with respect to patients included in population-based registries.
2013
Inglese
Latagliata, R., Ferrero, D., Iurlo, A., Cavazzini, F., Castagnetti, F., Abruzzese, E., Fava, C., Breccia, M., Annunziata, M., Stagno, F., Tiribelli, M., Binotto, G., Mansueto, G., Gozzini, A., Russo, S., Cavalli, L., Montefusco, E., Gugliotta, G., Cedrone, M., Russo Rossi, A., Avanzini, P., Pregno, P., Mauro, E., Spadea, A., Celesti, F., Giglio, G., Isidori, A., Crugnola, M., Calistri, E., Sora', F., D'Addosio, A., Rege Cambrin, G., Luciano, L., Alimena, G., Storti, S., Imatinib in very elderly patients with chronic myeloid leukemia in chronic phase: a retrospective study, <<DRUGS & AGING>>, 2013; 30 (8): 629-637. [doi:10.1007/s40266-013-0088-6] [http://hdl.handle.net/10807/51127]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10807/51127
Citazioni
  • ???jsp.display-item.citation.pmc??? 11
  • Scopus 34
  • ???jsp.display-item.citation.isi??? 33
social impact